Irwin James, Ferguson Emma, Simms Lisa A, Hanigan Katherine, Carbonnel Franck, Radford-Smith Graham
Inflammatory Bowel Diseases Research Group, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Department of Gastroenterology and Hepatology, Royal Brisbane and Women's Hospital, Brisbane, Australia.
PLoS One. 2017 Apr 6;12(4):e0174954. doi: 10.1371/journal.pone.0174954. eCollection 2017.
The Montreal classification of disease behaviour in Crohn's disease describes progression of disease towards a stricturing and penetrating phenotype. In the present paper, we propose an alternative representation of the long-term course of Crohn's disease complications, the rolling phenotype. As is commonly observed in clinical practice, this definition allows progression to a more severe phenotype (stricturing, penetrating) but also, regression to a less severe behaviour (inflammatory, or remission) over time.
All patients diagnosed with Crohn's Disease between 01/01/1994 and 01/03/2008, managed at a single centre and observed for a minimum of 5 years, had development and resolution of all complications recorded. A rolling phenotype was defined at each time point based on all observed complications in the three years prior to the time point. Phenotype was defined as B1, B2, B3, or B23 (penetrating and stenotic). The progression over time of the rolling phenotype was compared to that of the cumulative Montreal phenotype.
305 patients were observed a median of 10.0 (Intraquartile range 7.3-13.7) years. Longitudinal progression of rolling phenotype demonstrated a consistent proportion of patients with B1 (70%), B2 (20%), B3 (5%) and B23 (5%) phenotypes. These proportions were observed regardless of initial phenotype. In contrast, the cumulative Montreal phenotype progressed towards a more severe phenotype with time (B1 (39%), B2 (26%), B3(35%) at 10 years).
A rolling phenotype provides an alternative view of the longitudinal burden of intra-abdominal complications in Crohn's disease. From this viewpoint, 70% of patients have durable freedom from complication over time (>3 years).
克罗恩病的蒙特利尔疾病行为分类描述了疾病向狭窄型和穿透型表型的进展情况。在本文中,我们提出了克罗恩病并发症长期病程的另一种表示方式,即动态表型。正如临床实践中常见的那样,该定义允许随着时间推移进展为更严重的表型(狭窄型、穿透型),但也可能回归为不太严重的行为(炎症型或缓解型)。
所有在1994年1月1日至2008年3月1日期间在单一中心确诊为克罗恩病且至少观察5年的患者,其所有并发症的发生和缓解情况均有记录。基于该时间点前三年观察到的所有并发症,在每个时间点定义一个动态表型。表型定义为B1、B2、B3或B23(穿透型和狭窄型)。将动态表型随时间的进展与累积蒙特利尔表型的进展进行比较。
观察了305例患者,中位观察时间为10.0年(四分位间距7.3 - 13.7年)。动态表型的纵向进展显示,具有B1(70%)、B2(20%)、B3(5%)和B23(5%)表型的患者比例一致。无论初始表型如何,均观察到这些比例。相比之下,累积蒙特利尔表型随时间进展为更严重的表型(10年时B1为39%,B2为26%,B3为35%)。
动态表型为克罗恩病腹腔内并发症的纵向负担提供了另一种视角。从这个角度来看,70%的患者随着时间推移(超过3年)可持久无并发症。